Question

In: Accounting

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:

1

Dec. 31, 20Y3

Dec. 31, 20Y2

2

Assets

3

Cash

$625,650.00

$586,340.00

4

Accounts receivable (net)

228,170.00

208,030.00

5

Inventories

641,480.00

617,130.00

6

Investments

0.00

240,290.00

7

Land

328,170.00

0.00

8

Equipment

706,070.00

552,300.00

9

Accumulated depreciation-equipment

(165,580.00)

(147,010.00)

10

Total assets

$2,363,960.00

$2,057,080.00

11

Liabilities and Stockholders’ Equity

12

Accounts payable (merchandise creditors)

$424,300.00

$404,860.00

13

Accrued expenses payable (operating expenses)

41,850.00

52,880.00

14

Dividends payable

23,200.00

19,880.00

15

Common stock, $2 par

150,000.00

100,000.00

16

Paid-in capital: Excess of issue price over par—common stock

417,500.00

280,000.00

17

Retained earnings

1,307,110.00

1,199,460.00

18

Total liabilities and stockholders’ equity

$2,363,960.00

$2,057,080.00

The income statement for the year ended December 31, 20Y3, is as follows:

1

Sales

$5,378,129.00

2

Cost of goods sold

 3,306,510.00

3

Gross profit

$2,071,619.00

4

Operating expenses:

5

Depreciation expense

$18,570.00

6

Other operating expenses

1,755,879.00

7

Total operating expenses

1,774,449.00

8

Operating income

$297,170.00

9

Other income:

10

Gain on sale of investments

40,390.00

11

Income before income tax

$337,560.00

12

Income tax expense

133,650.00

13

Net income

$203,910.00

Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows:

a. The investments were sold for $280,680 cash.
b. Equipment and land were acquired for cash.
c. There were no disposals of equipment during the year.
d. The common stock was issued for cash.
e. There was a $96,260 debit to Retained Earnings for cash dividends declared.

Required

Prepare a statement of cash flows, using the direct method of presenting cash flows from operating activities.

Solutions

Expert Solution

Solution

Livers Inc

Cash Flow Statement using the direct method:

Cash Flow Statement (Direct Method of presenting cash flows from operating activities) for the year ended December 31, 20Y3j

Cash flow from operating activities:

Cash receipts from customers

$5,357,989

Cash paid to suppliers

($3,311,420)

Cash generated from operations

$2,046,569

Operating expenses paid

($1,766,909)

Income tax expense

($133,650)

Net cash provided by operating activities

$146,010

Cash flow from investing activities:

Proceeds from sale of investment

$280,680

Purchase of land

($328,170)

Purchase of equipment

($153,770)

Net cash provided by investing activities

($201,260)

Cash flow from financing activities:

Proceeds from issue of stock

$187,500

Dividends paid

($92,940)

Cash flow from financing activities

$94,560

Net increase in cash

$39,310

Beginning balance of cash

$586,340

Ending balance of cash

$625,650

Workings –

  1. Cash receipts from customers:

Sales                                                         $5,378,129

Less: increase in accounts receivable      $20,140

Cash receipts from customers                  $5,357,989

  1. Cash paid to suppliers:

Cost of goods sold                              $3,306,510

Add: increase in inventory                 $24,350

Less: increase in accounts payable    ($19,440)

Cash paid to suppliers                        $3,311,420

  1. Operating Expenses paid:

Operating expenses                                        $1,755,879

Add: decrease in accrued expenses payable $11,030

Operating expenses paid                                $1,766,909

  1. Dividends paid:

Cash Dividends declared        $96,260

Add: beginning balance         $19,880

Less: Ending balance             ($23,200)

Cash dividends paid               $92,940


Related Solutions

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $155,000.00 $150,000.00 4 Accounts receivable (net) 450,000.00 400,000.00 5 Inventories 770,000.00 750,000.00 6 Investments 0.00 100,000.00 7 Land 500,000.00 0.00 8 Equipment 1,400,000.00 1,200,000.00 9 Accumulated depreciation-equipment (600,000.00) (500,000.00) 10 Total assets $2,675,000.00 $2,100,000.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $340,000.00 $300,000.00 13 Accrued expenses payable (operating expenses) 45,000.00 50,000.00...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,640.00 $585,760.00 4 Accounts receivable (net) 226,900.00 208,390.00 5 Inventories 641,350.00 616,130.00 6 Investments 0.00 239,300.00 7 Land 328,730.00 0.00 8 Equipment 705,940.00 553,530.00 9 Accumulated depreciation-equipment (166,970.00) (148,000.00) 10 Total assets $2,362,590.00 $2,055,110.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $425,140.00 $404,540.00 13 Accrued expenses payable (operating expenses) 42,020.00...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,170.00 $585,760.00 4 Accounts receivable (net) 227,840.00 208,880.00 5 Inventories 641,390.00 616,790.00 6 Investments 0.00 240,820.00 7 Land 327,380.00 0.00 8 Equipment 704,290.00 554,020.00 9 Accumulated depreciation-equipment (167,160.00) (148,930.00) 10 Total assets $2,359,910.00 $2,057,340.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $424,670.00 $404,080.00 13 Accrued expenses payable (operating expenses) 43,080.00...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,170.00 $585,760.00 4 Accounts receivable (net) 227,840.00 208,880.00 5 Inventories 641,390.00 616,790.00 6 Investments 0.00 240,820.00 7 Land 327,380.00 0.00 8 Equipment 704,290.00 554,020.00 9 Accumulated depreciation-equipment (167,160.00) (148,930.00) 10 Total assets $2,359,910.00 $2,057,340.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $424,670.00 $404,080.00 13 Accrued expenses payable (operating expenses) 43,080.00...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,170.00 $585,760.00 4 Accounts receivable (net) 227,840.00 208,880.00 5 Inventories 641,390.00 616,790.00 6 Investments 0.00 240,820.00 7 Land 327,380.00 0.00 8 Equipment 704,290.00 554,020.00 9 Accumulated depreciation-equipment (167,160.00) (148,930.00) 10 Total assets $2,359,910.00 $2,057,340.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $424,670.00 $404,080.00 13 Accrued expenses payable (operating expenses) 43,080.00...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows:...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $625,820.00 $586,050.00 4 Accounts receivable (net) 227,530.00 209,880.00 5 Inventories 641,480.00 616,920.00 6 Investments 0.00 240,910.00 7 Land 327,510.00 0.00 8 Equipment 704,830.00 554,110.00 9 Accumulated depreciation-equipment (165,750.00) (148,570.00) 10 Total assets $2,361,420.00 $2,059,300.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $424,970.00 $405,330.00 13 Accrued expenses payable (operating expenses) 42,810.00...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $155,000.00 $150,000.00 4 Accounts receivable (net) 450,000.00 400,000.00 5 Inventories 770,000.00 750,000.00 6 Investments 0.00 100,000.00 7 Land 500,000.00 0.00 8 Equipment 1,400,000.00 1,200,000.00 9 Accumulated depreciation-equipment (600,000.00) (500,000.00) 10 Total assets $2,675,000.00 $2,100,000.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $340,000.00 $300,000.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,640.00 $585,760.00 4 Accounts receivable (net) 226,900.00 208,390.00 5 Inventories 641,350.00 616,130.00 6 Investments 0.00 239,300.00 7 Land 328,730.00 0.00 8 Equipment 705,940.00 553,530.00 9 Accumulated depreciation-equipment (166,970.00) (148,000.00) 10 Total assets $2,362,590.00 $2,055,110.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $425,140.00 $404,540.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $155,000.00 $150,000.00 4 Accounts receivable (net) 450,000.00 400,000.00 5 Inventories 770,000.00 750,000.00 6 Investments 0.00 100,000.00 7 Land 500,000.00 0.00 8 Equipment 1,400,000.00 1,200,000.00 9 Accumulated depreciation-equipment (600,000.00) (500,000.00) 10 Total assets $2,675,000.00 $2,100,000.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $340,000.00 $300,000.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $262,580 $246,510 Accounts receivable (net) 95,120 88,540 Inventories 268,530 262,130 Investments 0 101,560 Land 137,730 0 Equipment 296,270 231,760 Accumulated depreciation—equipment (69,360) (62,500) Total assets $990,870 $868,000 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $179,350 $171,000 Accrued expenses payable (operating expenses) 17,840 22,570 Dividends payable 9,910 7,810 Common stock, $10 par 53,510 42,530 Paid-in...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT